Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric Lefkofsky sold 17,458 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $1,303,239.70. Following the sale, the chief executive officer directly owned 2,020,042 shares in the company, valued at $150,796,135.30. This trade represents a 0.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Tempus AI Stock Up 4.7%
TEM stock traded up $3.43 during trading on Thursday, hitting $76.71. 15,579,085 shares of the stock traded hands, compared to its average volume of 12,600,730. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $91.45. The firm's 50 day moving average is $63.48 and its two-hundred day moving average is $58.98. The stock has a market cap of $13.33 billion, a price-to-earnings ratio of -64.46 and a beta of 4.98. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same period in the prior year, the firm posted ($6.86) EPS. Tempus AI's revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.
Analyst Ratings Changes
Several equities analysts have issued reports on the stock. Guggenheim upped their target price on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Morgan Stanley upped their target price on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. BTIG Research upped their target price on shares of Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Bank of America upped their target price on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $67.64.
Check Out Our Latest Stock Report on TEM
Hedge Funds Weigh In On Tempus AI
Institutional investors have recently made changes to their positions in the business. First Horizon Advisors Inc. increased its holdings in Tempus AI by 12.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company's stock worth $89,000 after acquiring an additional 208 shares in the last quarter. Wells Fargo & Company MN increased its holdings in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after acquiring an additional 278 shares in the last quarter. PNC Financial Services Group Inc. increased its holdings in Tempus AI by 6.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company's stock worth $318,000 after acquiring an additional 287 shares in the last quarter. Concord Wealth Partners increased its holdings in Tempus AI by 308.0% in the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock worth $26,000 after acquiring an additional 308 shares in the last quarter. Finally, Sigma Planning Corp increased its holdings in Tempus AI by 1.0% in the 2nd quarter. Sigma Planning Corp now owns 33,834 shares of the company's stock worth $2,150,000 after acquiring an additional 319 shares in the last quarter. Institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.